Exact Mass: 371.03983080000006
Exact Mass Matches: 371.03983080000006
Found 112 metabolites which its exact mass value is equals to given mass value 371.03983080000006,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tetraconazole
CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9343; ORIGINAL_PRECURSOR_SCAN_NO 9342 CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9319; ORIGINAL_PRECURSOR_SCAN_NO 9317 CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9334; ORIGINAL_PRECURSOR_SCAN_NO 9331 CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9370; ORIGINAL_PRECURSOR_SCAN_NO 9366 CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9361; ORIGINAL_PRECURSOR_SCAN_NO 9360 CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9358; ORIGINAL_PRECURSOR_SCAN_NO 9356 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3723 D016573 - Agrochemicals D010575 - Pesticides
Sipatrigine
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D049990 - Membrane Transport Modulators D020011 - Protective Agents
Arotinolol
C15H21N3O2S3 (371.07958460000003)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Arotinolol is a nonselective α/β-adrenergic receptor blocker and a vasodilating β-blocker[1]. Arotinolol also shows potency for inhibiting the binding of the radioligand 125I-ICYP to 5HT1B-serotonergic receptor sites[2]. Arotinolol is an antihypertensive agent for the treatment of a variety of cardiovascular pathologies as well as non-cardiovascular diseases[1].
Carboplatin
Carboplatin is only found in individuals that have used or taken this drug. It is an organoplatinum compound that possesses antineoplastic activity. [PubChem]Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations. D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent > C1450 - Platinum Compound D000970 - Antineoplastic Agents
Salicyluric beta-D-glucuronide
C15H17NO10 (371.08524220000004)
Salicyluric beta-D-glucuronide, also known as 1-O-salicyluroyl-beta-D-glucuronate or 1-O-[N-(2-hydroxybenzoyl)glycyl]-beta-D-glucronate, is a member of the class of compounds known as O-glucuronides. O-glucuronides are glucuronides in which the aglycone is linked to the carbohydrate unit through an O-glycosidic bond.
N,N-Bis(2-chloroethyl)-N',N'-diphenylphosphoric triamide
C16H20Cl2N3OP (371.07209800000004)
Arotinolol
C15H21N3O2S3 (371.07958460000003)
PYR-41
C17H13N3O7 (371.07534680000003)
Phosphatase
C6H16NNa2O12P (371.02055060000004)
Phosphatase, also known as 4-nitrophenylphosphate or dipotassium nitrophenylphosphate, is a member of the class of compounds known as phenyl phosphates. Phenyl phosphates are aromatic organooxygen compounds containing a phosphate group, which is O-esterified with a phenyl group. Phosphatase can be found in a number of food items such as french plantain, fenugreek, pineapple, and horseradish, which makes phosphatase a potential biomarker for the consumption of these food products. A phosphatase is an enzyme that uses water to cleave a phosphoric acid monoester into a phosphate ion and an alcohol. Because a phosphatase enzyme catalyzes the hydrolysis of its substrate, it is a subcategory of hydrolases. Phosphatase enzymes are essential to many biological functions, because phosphorylation (e.g. by protein kinases) and dephosphorylation (by phosphatases) serve diverse roles in cellular regulation and signaling. Whereas phosphatases remove phosphate groups from molecules, kinases catalyze the transfer of phosphate groups to molecules from ATP. Together, kinases and phosphatases direct a form of post-translational modification that is essential to the cells regulatory network. Phosphatase enzymes are not to be confused with phosphorylase enzymes, which catalyze the transfer of a phosphate group from hydrogen phosphate to an acceptor. Due to their prevalence in cellular regulation, phosphatases are an area of interest for pharmaceutical research .
N-(3-Cyano-1H-indol-5-yl)-3-[4-(trifluoromethoxy)phenyl]acrylamide
3-{3-[2-hydroxybut-3-en-1-yl]-1,2,4-thiadiazol-5-yl}-5,6-dihydrospiro[indoline-3,2-thiopyran]-2-one
Tetraconazole
D016573 - Agrochemicals D010575 - Pesticides
(6R-trans)-7-amino-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
C12H13N5O5S2 (371.03580880000004)
N,N,N,N-Tetramethyl-S-(1-oxido-2-pyridyl)thiuronium hexafluorophosphate
2-N-BOC-3-(3-BROMO-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID
C16H22BrNO4 (371.07321120000006)
3-Bromo-9-(1-naphthyl)-9H-carbazole
C22H14BrN (371.03095440000004)
Benzyl (S)-3-(Boc-amino)-4-bromobutanoate
C16H22BrNO4 (371.07321120000006)
2-N-BOC-3-(4-BROMO-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID
C16H22BrNO4 (371.07321120000006)
Irsogladine Maleate
C13H11Cl2N5O4 (371.01880660000006)
D020011 - Protective Agents > D011837 - Radiation-Protective Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents
1-{4-[3,5-DI(TRIFLUOROMETHYL)PHENOXY]PHENYL}-1H-PYRROLE
TERT-BUTYL 4-((4-BROMOPHENYL)THIO)PIPERIDINE-1-CARBOXYLATE
C16H22BrNO2S (371.05545320000004)
METHYL 2-N-BOC-2-AMINOMETHYL-3-(3-BROMO-PHENYL)-PROPIONATE
C16H22BrNO4 (371.07321120000006)
1H-1,3,4-Benzotriazepine,2-(2-thienyl)-5-[4-(trifluoromethyl)phenyl]-(9CI)
6-BROMO-2-(4-ETHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
4-((4-(4-BROMO-1H-PYRAZOL-1-YL)PHENYL)SULFONYL)MORPHOLINE
C13H14BrN3O3S (370.9939194000001)
METHYL 2-N-BOC-2-AMINOMETHYL-3-(4-BROMO-PHENYL)-PROPIONATE
C16H22BrNO4 (371.07321120000006)
4-Nitrophenyl phosphate disodium hexahydrate
C6H16NNa2O12P (371.02055060000004)
1-[(1,3,4-trimethyl-4,5-dihydroimidazol-1-ium-2-yl)oxy]pyrrolidine-2,5-dione,hexafluorophosphate
O-Succinimidyl-1,3-dimethylpropyleneuronium hexafluorophosphate
C10H16N3O3.PF6 (371.08334279999997)
2-Bromo-9-(2-naphthyl)-9H-carbazole
C22H14BrN (371.03095440000004)
tert-butyl 4-broMo-2-fluorobenzyl(cyclopentyl)carbaMate
tert-butyl 4-broMo-3-fluorobenzyl(cyclopentyl)carbaMate
N-ethyl-1,1,2,2,3,3,4,4,4-nonafluoro-N-(2-hydroxyethyl)butane-1-sulphonamide
C8H10F9NO3S (371.0237658000001)
5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole
N-(2-Benzoyl-4-chlorophenyl)-3,4-difluorobenzamide
C20H12ClF2NO2 (371.05245859999997)
5-Bromo-3-(Pyrrolidin-1-Ylsulfonyl)-1h-Indole-2-Carboxamide
C13H14BrN3O3S (370.9939194000001)
Batabulin
C13H7F6NO3S (371.0050824000001)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
Denotivir
C18H14ClN3O2S (371.04952140000006)
C254 - Anti-Infective Agent > C281 - Antiviral Agent
2-(3-Pyridinyl)-4-[4-(1-pyrrolidinylsulfonyl)phenyl]thiazole
Remdesivir nucleoside monophosphate
C12H14N5O7P (371.06308240000004)
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-[6-acetyl-3-(1,3-benzothiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]acetamide
N-[4-[[[[oxo(thiophen-2-yl)methyl]amino]-sulfanylidenemethyl]amino]phenyl]-2-furancarboxamide
C17H13N3O3S2 (371.03983080000006)
3-{[(3-Fluoro-3-Methoxybiphenyl-4-Yl)amino]carbonyl}thiophene-2-Carboxylic Acid
C19H14FNO4S (371.06275360000006)
N-(4-Acetylphenyl)-5-(5-chloro-2,4-dihydroxyphenyl)-1H-pyrazole-4-carboxamide
C18H14ClN3O4 (371.0672794000001)
2-(Cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate
[(2R,3S,4R,5S)-5-(4-amino-5-cyanopyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
C12H14N5O7P (371.06308240000004)
Paraplatin
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XA - Platinum compounds D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents D000970 - Antineoplastic Agents
7-Benzoyl-3-chloroindolizine-1,2-dicarboxylic acid dimethyl ester
C19H14ClNO5 (371.05604640000007)
2-(2,5-dichlorophenyl)sulfonyl-N-methyl-N-[(2-methylphenyl)methyl]ethanamine
C17H19Cl2NO2S (371.05134940000005)
2-[(3,4-Dichlorophenyl)methylthio]-6-(3-pyridinyl)-3-pyridinecarbonitrile
C18H11Cl2N3S (371.00507060000007)
4-[5-Amino-3-methyl-4-[oxo-[3-(trifluoromethyl)phenyl]methyl]-2-thiophenyl]butanoic acid
1-(2-Methoxyethyl)-7-thiophen-2-yl-5-(trifluoromethyl)pyrido[2,3-d]pyrimidine-2,4-dione
3-(1,3-benzothiazol-2-ylsulfanyl)-N-[(E)-(4-methoxyphenyl)methylideneamino]propanamide
4-[(1-Methyl-5-tetrazolyl)thio]-5-(4-nitrophenyl)thieno[2,3-d]pyrimidine
ethyl 4-{(4E)-4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl}benzoate
C17H13N3O7 (371.07534680000003)
(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-(5-(3-Methoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-YL)-isonicotinamide
C17H13N3O3S2 (371.03983080000006)
BW619c89
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D049990 - Membrane Transport Modulators D020011 - Protective Agents
GS-441524 monophosphate
C12H14N5O7P (371.06308240000004)
A C-nucleoside phosphate that is GS-441524 in which the 5-hydroxy group has been replaced by a phosphate group. In cells, GS-441524 monophosphate gets converted into the pharmacologically active triphosphate form (GS-443902).
AS1949490
C20H18ClNO2S (371.07467180000003)
AS1949490 is a potent, orally active, selective SHIP2 phosphatase inhibitor with IC50 values of 0.34, 0.62, 13, >50, >50, and >50 μM for Mouse SHIP2, Human SHIP2, Human SHIP1, Human PTEN, Human synaptojanin, and Human myotubularin, respectively. AS1949490 increases the phosphorylation of Akt, glucose consumption and glucose uptake. AS1949490 activates intracellular insulin signalling pathways. AS1949490 can be used for research of diabetes[1][2].
Azemiglitazone
C19H17NO5S (371.08273920000005)
Azemiglitazone (MSDC-0602) is an orally active thiazolidinedione (TZD) -like molecule, which binds to PPARγ with low binding and activating affinity. Azemiglitazone inhibits mitochondrial pyruvate carrier (MPC), which inhibits Alzheimer’s disease and diminishes nonalcoholic steatohepatitis (NASH) caused liver injury[4][5].
Quinotolast sodium
C17H12N6NaO3 (371.08685420000006)
Quinotolast sodium in the concentration range of 1-100 μg/mL inhibits histamine, LTC4 and PGD2 release in a concentration-dependent manner.
5-hydroxy-3,4-bis(4-hydroxy-3-nitrophenyl)pyrrol-2-one
2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}propanoic acid
C18H13NO8 (371.06411380000003)
2-(6-aminopurin-9-yl)-5-[(dimethylarsoryl)methyl]oxolane-3,4-diol
C12H18AsN5O4 (371.05746880000004)
7,8-dimethoxy-3,4-methylenedioxy-10-nitro-1-phenanthrenecarboxylic acid
C18H13NO8 (371.06411380000003)
{"Ingredient_id": "HBIN012987","Ingredient_name": "7,8-dimethoxy-3,4-methylenedioxy-10-nitro-1-phenanthrenecarboxylic acid","Alias": "NA","Ingredient_formula": "C18H13NO8","Ingredient_Smile": "NA","Ingredient_weight": "371.3","OB_score": "NA","CAS_id": "79185-74-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7476","PubChem_id": "NA","DrugBank_id": "NA"}
7-methoxy-aristolochiacacid
C18H13NO8 (371.06411380000003)
{"Ingredient_id": "HBIN013335","Ingredient_name": "7-methoxy-aristolochiacacid","Alias": "NA","Ingredient_formula": "C18H13NO8","Ingredient_Smile": "COC1=CC2=CC(=C3C(=CC4=C(C3=C2C=C1OC)OCO4)C(=O)O)[N+](=O)[O-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13836","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-methoxy-aristolochiac acid a
C18H13NO8 (371.06411380000003)
{"Ingredient_id": "HBIN013336","Ingredient_name": "7-methoxy-aristolochiac acid a","Alias": "3,4-Methylenedioxy-7,8-dimethoxy-10-nitrophenanthrene-1-carboxylic acid; AC1NSY17; 7-methoxyaristolochic acid a; 79185-74-3; 8,9-dimethoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid","Ingredient_formula": "C18H13NO8","Ingredient_Smile": "COC1=CC=CC2=C1C(=C(C3=C2C4=C(C=C3C(=O)O)OCO4)[N+](=O)[O-])OC","Ingredient_weight": "371.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT19335","TCMID_id": "31525","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "46233015","DrugBank_id": "NA"}
aristolochicacid d methyl ether
C18H13NO8 (371.06411380000003)
{"Ingredient_id": "HBIN016804","Ingredient_name": "aristolochicacid d methyl ether","Alias": "NA","Ingredient_formula": "C18H13NO8","Ingredient_Smile": "COC1=CC2=C3C(=C(C=C2C(=C1)OC)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1714","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}propanoic acid
C18H13NO8 (371.06411380000003)
(2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-5-[(dimethylarsoryl)methyl]oxolane-3,4-diol
C12H18AsN5O4 (371.05746880000004)